NVO - Australia to ban copycat versions of weight loss drugs like Ozempic
2024-05-22 07:14:37 ET
More on Eli Lilly, Novo Nordisk, etc.
- Eli Lilly: Great Time To Divest Before It Potentially Crashes
- Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
- The FTC Cracks Down On Novo Nordisk's Ozempic
- Study finds 30% of Wegovy, Saxenda users quit within 4 weeks
- Novo Nordisk unsure when it will meet obesity drug demand: report